Making Decisions About the Measles-Mumps-Rubella Vaccine
NCT01369394 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 79
Last updated 2014-12-10
Summary
The goal of this study is to determine whether a computer-based intervention that delivers individually-tailored educational messages about the MMR vaccine increases MMR vaccine-hesitant parents' intentions to have their children vaccinated.
Conditions
Interventions
- OTHER
-
Behavioral: Computer-based tailoring system
Both the intervention and control groups will use a computer-based tailoring system to respond to survey questions. The computer-based tailoring system will generate educational messages based on participants' responses to survey questions. The intervention group will receive tailored educational messages, whereas the control group will receive generic educational messages. The tailored and generic educational messages will be presented as to look like web pages. However, the messages will only exist on the study computer, and will not be linked to any "live" server or website.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Amanda Dempsey, MD, PhD, MPH · Children's Outcomes Research Program
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-06-30
- Primary Completion
- 2012-06-30
- Completion
- 2012-07-31
Countries
- United States
Study Locations
More Related Trials
-
Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age
NCT00861744 ·Status: COMPLETED ·Phase: PHASE2
-
Vaccine Social Media Randomized Intervention Trial
NCT01873040 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age
NCT02184572 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life
NCT01681992 ·Status: COMPLETED ·Phase: PHASE3
-
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age
NCT06855160 ·Status: RECRUITING ·Phase: PHASE3
-
Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR)
NCT06331702 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Controlled Trial of Measles Vaccination Schedule
NCT03170765 ·Status: UNKNOWN ·Phase: NA
-
Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age
NCT01702428 ·Status: COMPLETED ·Phase: PHASE3
-
Is a Third Dose of MMRV Vaccine Beneficial for the Adult Population in Alberta?
NCT05923970 ·Status: RECRUITING
-
Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers
NCT01188343 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live
NCT05161845 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age
NCT00578175 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)
NCT00092391 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine
NCT00406211 ·Status: COMPLETED ·Phase: PHASE3
-
Study on Immunization Schedule of Beijing Tiantan Biological's Measles-mumps-rubella(MMR) Vaccine
NCT03160820 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity of Co-administration of Measles and Japanese Encephalitis Vaccines
NCT02643433 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months
NCT06399003 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR Vaccine
NCT02153866 ·Status: UNKNOWN ·Phase: PHASE4
-
Use of SMS and Interactive Reminders to Improve Timely Immunization Coverage
NCT03379467 ·Status: COMPLETED ·Phase: NA
-
Edtech-HPV: A Community Approach Using Education and Technology to Increase HPV Vaccination
NCT03209713 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines
NCT01738841 ·Status: WITHDRAWN
-
Determining Long-Term Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine
NCT00412516 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Pediatric Heart Transplantation Patients
NCT07195032 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluation of Immunogenicity and Safety of Combined Immunization of sIPV, DTaP and MMR
NCT04638985 ·Status: UNKNOWN ·Phase: PHASE4
-
Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children
NCT00197015 ·Status: COMPLETED ·Phase: PHASE3